Literature DB >> 8025072

Cells perpetuating the inflammatory response in scleritis.

W Bernauer1, P G Watson, B Daicker, S Lightman.   

Abstract

Scleritis can be a destructive disease frequently associated with autoimmune disorders. It is believed that primary vasculitis plays an important role in its pathogenesis, but little is known about the cellular effector mechanisms. The purpose of this study was to analyse the inflammatory cellular infiltrate in scleritis. Six episcleral biopsies and two enucleated eyes were studied. The episcleral biopsies were taken from patients with nodular scleritis. In one patient enucleation was done after perforation in anterior necrotising scleritis and, in the other after misdiagnosis of posterior scleritis as intraocular tumour. Morphological criteria and immunohistochemical methods were used to characterise the inflammatory cellular infiltrate. The inflammatory cells infiltrating the episcleral tissue were mainly T lymphocytes and macrophages. There was a predominance of CD4 positive cells, but only few lymphocytes were activated (expressed IL-2 receptor). The cells infiltrating the scleral fibres in the enucleated eyes consisted in both cases predominantly of T cells. Clusters of B cells were found in perivascular areas. In circumscribed areas neutrophils, macrophages, and plasma cells were part of the scleral infiltrate. Signs of a granulomatous process with activated macrophages (epithelioid and giant cells) were present in necrotising scleritis. Expression of major histocompatibility class II molecules (MHC II) was found on lymphocytes and rarely on macrophages. Signs of primary vasculitis were not found in any of the specimens. The cellular infiltrate in scleritis shows, at least at certain stages, features compatible with a T cell mediated (autoimmune) disorder, which may have major therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025072      PMCID: PMC504792          DOI: 10.1136/bjo.78.5.381

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Monoclonal-antibody therapy in systemic vasculitis.

Authors:  P W Mathieson; S P Cobbold; G Hale; M R Clark; D B Oliveira; C M Lockwood; H Waldmann
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

Review 2.  Posterior scleritis.

Authors:  W E Benson
Journal:  Surv Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 6.048

3.  Necrogranulomatous scleritis. Clinical and histologic features.

Authors:  D Sevel
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

4.  Use of cyclosporin in the management of steroid dependent non-necrotising scleritis.

Authors:  K N Hakin; J Ham; S L Lightman
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

5.  Cyclosporin therapy for severe scleritis.

Authors:  D Wakefield; P McCluskey
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

6.  Anterior segment fluorescein angiography in the diagnosis of scleral inflammation.

Authors:  P G Watson; E Bovey
Journal:  Ophthalmology       Date:  1985-01       Impact factor: 12.079

7.  The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis.

Authors:  W Bernauer; P Wright; J K Dart; J N Leonard; S Lightman
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

8.  Necrotizing scleritis. A clinico-pathologic study of 41 cases.

Authors:  N A Rao; G E Marak; A A Hidayat
Journal:  Ophthalmology       Date:  1985-11       Impact factor: 12.079

9.  Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

Authors:  J C Jennette; A S Wilkman; R J Falk
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

10.  Microscopical studies of necrotising scleritis. I. Cellular aspects.

Authors:  R D Young; P G Watson
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

View more
  7 in total

1.  Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.

Authors:  Nirali Bhatt; Monica Dalal; William Tucker; Dominic Obiyor; Robert Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2014-12-17       Impact factor: 5.258

2.  Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation.

Authors:  Toshio Hisatomi; Koh-hei Sonoda; Fumihiko Ishikawa; Hong Qiao; Takahiro Nakazawa; Mitsuhiro Fukata; Toru Nakamura; Kousuke Noda; Shinsuke Miyahara; Mine Harada; Shigeru Kinoshita; Ali Hafezi-Moghadam; Tatsuro Ishibashi; Joan W Miller
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

Review 3.  [Diseases of the outer eye in rheumatoid arthritis].

Authors:  E Feist; U Pleyer
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

Review 4.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

Review 5.  Scleritis and peripheral ulcerative keratitis.

Authors:  Anat Galor; Jennifer E Thorne
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

6.  Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials.

Authors:  Manjeet S Bhamra; Irfan Gondal; Abhimanyu Amarnani; Saul Betesh; Angelina Zhyvotovska; Wayne Scott; Milena Rodriguez-Alvarez; Douglas R Lazzaro; Isabel M McFarlane
Journal:  Int J Clin Res Trials       Date:  2019-11-09

7.  The Innate Immune Cell Profile of the Cornea Predicts the Onset of Ocular Surface Inflammatory Disorders.

Authors:  Amaya Pérez Del Palomar; Alberto Montolío; José Cegoñino; Sandeep Kumar Dhanda; Chit Tong Lio; Tanima Bose
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.